SNOMED CT-concept
|
waarneembare entiteit (waarneembare entiteit)
waarneembare entiteit
Observable entity
Id
363787002
Status
Primitive
Global Patient Set
|
aankleuringspatroon van 'mass enhancement' in laesie mamma met magnetic resonance imaging
aankleuringspatroon van 'non-mass enhancement' in laesie van mamma met magnetic resonance imaging
Age AND/OR growth period
15
algemene klinische toestand
37
Antimicrobial susceptibility of organism by matrix assisted laser desorption ionization time of flight mass spectrometry
Assessment score
145
bepaling van antilichamen tegen SARS-CoV-2
bepaling van SARS-CoV-2-antigeen
1
Clinical history/examination observable
150
Clinical performance measure
3
Concentration of 1,5-anhydroglucitol
Concentration of neurotransmitter in blood
Cycle threshold for nucleic acid detection in specimen using real-time polymerase chain reaction
detectie van antilichamen tegen SARS-CoV-2
detectie van SARS-CoV-2
2
Detection and differentiation of antibody to human immunodeficiency virus type 1 and human immunodeficiency virus type 2 by immunoassay
Detection of opiate by screening method
Differential count of white blood cells by automated method
Differential count of white blood cells by manual method
Disease activity score using 28 joint count
1
Environment observable
10
faciliteiten benodigd bij consult
Feature of entity
12
geschiktheid om deel te nemen aan klinische studie
Hematology observable
5
Histologic grade of dysplasia at proximal surgical margin
histologische type van eenduidig benigne laesie
histologische type van niet eenduidig benigne laesie
Identification code
6
Identification of bacteria by matrix assisted laser desorption ionization time of flight mass spectrometry
Identification of fungus by matrix assisted laser desorption ionization time of flight mass spectrometry
Imaging observable
25
in aanmerking komende klinische studies
Indocyanine green clearance rate
interpretatie van bevindingen
24
Laboratory biosafety level
Lactate in umbilical cord blood
Length of cross section of myometrium in uterus specimen
mate van blootstelling aan daglicht
Measurement of heme oxygenase-1
Molecular, genetic AND/OR cellular observable
4
Monitoring features
4
Number of occurrences observable
4
observatie betreffende behandeling met geneesmiddel
24
observatie betreffende functioneren
118
observatie betreffende lichaamsvloeistof
9
observatie betreffende lymfeklier
18
observatie betreffende sociale en persoonlijke voorgeschiedenis
24
Observation using immunohistochemistry
32
Parameter
3
Population statistic
4
Prescription observable
6
Presence of Helicobacter pylori in stool
Presence of macroscopic perforation of colon by primary malignant neoplasm of colon
Presence of macroscopic perforation of small intestine by primary malignant neoplasm of small intestine
Presence of microcalcification in excised breast specimen
Presence of necrosis in excised breast specimen
Presence of thrombus in renal vein
Process
6
Proliferative mass observable
2
Radiation therapy observable
1
reden voor afwijken van richtlijnen
Rhesus antibody observable
Risk level
5
Specimen observable
56
Status of intactness of mesorectal specimen
Status of intactness of renal capsule in excised kidney specimen
status van patiëntcontact in multidisciplinair overleg
Substance observable
5
Surgical margin observable
18
Temporal observable
70
trigger
type consult
type gedrag en/of manier van communiceren bij benaderen van zorgafnemer
urgentie
Viral load
zorgfase
zorgvormtype van onvrijwillige zorg
